Search Results
271 Results for 'Therapeutics & Vaccines'
PAGE 2 OF 11
Technology
Microorganisms And Methods For Producing Reuterin
UW-Madison researchers have developed a method to optimize the production of reuterin in bacterial cells that contain the reuterin production pathway (i.e., the pdu operon). The inventors compared the...
Learn More
Learn More
Jan Peter Van Pijkeren, Zhiying Wang | P230254US02
Technology
Turbinmicin Compounds, Compositions And Uses Thereof
The present invention from UW-Madison researchers is a small molecule antifungal agent isolated from a bacterial species found in the sea squirt Ecteinascidia turbinate. The inventors collected the sp...
Learn More
Learn More
Timothy Bugni, Fan Zhang, Douglas Braun, David Andes, Miao Zhao | P180376US02
Technology
METHOD FOR PREVENTING ADVERSE PREGNANCY OUTCOMES DUE TO USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) DURING GESTATION
UW-Madison researchers have discovered methods for alleviating the adverse effects of SSRIs in pregnancy through the co-administration of the known drug ketanserin. Using several in vivo experimental ...
Learn More
Learn More
Laura Hernandez, Rafael Reis Domingues, Milo Wiltbank | P230203US02
Technology
COMPOSITIONS AND METHODS TO ENHANCE IMMUNE CHECKPOINT BLOCKADE THERAPY AGAINST HYPOXIC TUMORS
UW-Madison researchers have developed an improved delivery system that is able to penetrate the extracellular matrix (ECM) and shuttle surface-conjugated protein cages, composed of collagenases and an...
Learn More
Learn More
Quanyin Hu, Zhaoting Li | P230298WO01
Technology
FERRITIN-TARGETING PROTACS AND METHODS OF INDUCING PYROPTOSIS
UW-Madison researchers have developed ferritin-targeting proteolysis targeting chimeras (PROTACs) to establish an iron excess stress inside cancer cells. The PROTAC structure contains oleic acid for b...
Learn More
Learn More
Quanyin Hu, Yu Chen | P230104WO01
Technology
HELA-ADAPTED RHINOVIRUSES C (RV-C) AND ADAPTIVE GENOMIC MUTATIONS
UW-Madison researchers have developed HeLa cell-adapted Rhinovirus-C (RV-C) variants that induce a strong cytopathic effect and replicate vigorously in HeLa-E8 cells. The inventors had previously show...
Learn More
Learn More
James Gern, Yury Bochkov | P240269US01
Technology
REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION
UW-Madison researchers have developed a reporter cell line for identifying compounds that promote endothelial cell differentiation and nitric oxide production and identified four compounds that promot...
Learn More
Learn More
James Thomson, Jue Zhang | P230071US02
Technology
VACCINE ADJUVANTS, TRANSFECTION REAGENTS, AND METHODS OF USING THE SAME
UW-Madison researchers have developed a new combination adjuvant composition (dubbed QTAP) that combines two safe adjuvants (Quil-A and DOTAP) using a nanoparticle preparation protocol developed by th...
Learn More
Learn More
Adel Talaat, Bubacarr Touray | P220343US02
Technology
Derivatives Of Turbinmicin As Antifungal Agents
The present invention from UW-Madison researchers is a set of analogs of turbinmicin that show similar efficacy but are more soluble than the parent molecule. The parent molecule proved to be fairly i...
Learn More
Learn More
Timothy Bugni, Weiping Tang, Le Guo, Changgui Zhao, Fan Zhang, Douglas Braun, David Andes, Miao Zhao, Jenna Fossen | P200353US02
Technology
METHODS OF INDUCING CARDIAC CELL PROLIFERATION AND INDUCING HEART REGENERATION
UW-Madison researchers have discovered that inducing expression of the protein LRRC10 in mouse hearts promotes heart regeneration. Neonatal mice have hearts that naturally regenerate for the first wee...
Learn More
Learn More
Ahmed Mahmoud, Timothy Kamp, Youngsook Lee | P230238US02
Technology
IDENTIFICATION AND APPLICATION OF SELECTIVE CELL SURFACE MARKERS AND ADDITIONAL METHODS FOR HUMAN RED/GREEN CONE PHOTORECEPTOR PRECURSOR ENRICHMENT
UW-Madison researchers have discovered a cell-surface marker (CD166) that can be used to distinguish (and purify) cells that are immature (early) cone photoreceptor precursor cells (CPPs), which will ...
Learn More
Learn More
David Gamm, Praveen Joseph Susai Manickam, Michael Phillips, Elizabeth Capowski | P220285US02
Technology
IMPROVED INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT
UW-Madison researchers have identified new mutations that promote replication of influenza A viruses to high titers in embryonated chicken eggs and would therefore increase the manufacturing yield for...
Learn More
Learn More
Yoshihiro Kawaoka, Gabriele Neumann, Lizheng Guan | P230109US02
Technology
Washed Platelet Extract
UW-Madison researchers have developed a washed platelet extract with increased platelet growth factor concentration and decreased total protein relative to platelet rich plasma, and methods of making ...
Learn More
Learn More
Jacques Galipeau, Sabrina Brounts, Andrea Pennati | P190172US03
Technology
CRYPTIC PROTEINS EXPRESSED FROM DEFECTIVE VIRAL GENOMES INTERFERE WITH INFLUENZA VIRUS REPLICATION
UW-Madison researchers have developed methods for making and using modified influenza gene products, alone or in combination, to inhibit WT virus replication, to serve as immunostimulatory agents, or ...
Learn More
Learn More
Andrew Mehle, Jordan Ranum, Mitchell Ledwith | P230056US02
Technology
Synthetic IL6-IL1beta Fusion Cytokine For Promoting T Cell Cytotoxic Function, T Cell Proliferation, and Anti-Tumoricidal Activity
UW researchers have created a biological therapeutic that stimulates the immune system to fight solid tumors. The researchers fused the cytokines IL-6 and IL- together to form a bifunctional biomol...
Learn More
Learn More
Jacques Galipeau, Rahul Das | P220203US03
Technology
Synthetic Protein For Inducing Immune Tolerance
The present invention from UW Madison researchers is a fusion protein made of the full length PDL-1 transmembrane protein and full length IDO cytosolic protein which the inventors termed PIDO. These t...
Learn More
Learn More
Jacques Galipeau, Pradyut Paul | P200100US02
Technology
MUCOADHESIVE PROBIOTIC BACKPACKS WITH ROS NANO-SCAVENGERS ENHANCE THE BACTERIOTHERAPY FOR INFLAMMATORY BOWEL DISEASES
UW-Madison researchers have developed a novel platform that can selectively and sustainably scavenge ROS in inflamed colon tissues while also improving probiotic delivery for gut microbiota homeostasi...
Learn More
Learn More
Quanyin Hu, Jun Liu | P220262WO01
Technology
UW researchers have identified a molecule commonly used as a vaccine adjuvant to add to the combination of radiation therapy and checkpoint inhibitor treatment to drive the immune system’s response ...
Learn More
Learn More
Zachary Morris, Justin Jagodinsky | P220308WO01
Technology
Compositions and Methods to Enhance Therapeutic Efficacy of Cancer Therapies
UW researchers have identified a molecule commonly used as a vaccine adjuvant to add to the combination of radiation therapy and checkpoint inhibitor treatment to drive the immune system’s response ...
Learn More
Learn More
Zachary Morris, Justin Jagodinsky | P220308US02
Technology
Synthetic Ligands that Modulate the Activity of the RhlR Quorum Sensing Receptor
UW Madison researchers have developed RhlR modulators including agonist and antagonists which are useful for modulating QS phenotypes in Gram-negative bacteria. Certain compounds of general formula A-...
Learn More
Learn More
Helen Blackwell, Joseph Moore, Michelle Boursier | P160350US02
Technology
Methods Of Treating Hypogonadotropic Hypogonadism And Cognition Impairment Following A Traumatic Brain Injury
The UW/VA inventor showed that hCG raises circulating sex hormone levels in a mouse model for TBI as compared to sham treated mice. The data indicated that 1) craniectomy is sufficient to induce persi...
Learn More
Learn More
Craig Atwood | P210252US02
Technology
METHOD FOR SELECTING ANTIGENIC VIRAL VACCINE AND THERAPEUTIC SEQUENCES
UW-Madison researchers, in collaboration with a professor from the University of Missouri, propose using the cryptic lineages (4-24 amino acid substitutions) of the SARS-CoV-2 spike protein sequence t...
Learn More
Learn More
David O'Connor, Thomas Friedrich, Marc Johnson | P230004US02
Technology
SARS-COV-2 LACKING THE ENVELOPE PROTEIN AS AN ATTENUATED VACCINE VIRUS AGAINST COVID-19
UW-Madison researchers have developed a SARS-CoV-2 live-attenuated vaccine virus based on the original Wuhan genome but lacking the envelope (E) open reading frame. This vaccine virus replicates effic...
Learn More
Learn More
Yoshihiro Kawaoka, Peter Halfmann, Makoto Kuroda | P220270WO01
Technology
HYDROGEL COMPOSITIONS COMPRISING GASDERMIN D AND AN ESCRT INHIBITOR AND METHODS OF USE THEREOF
UW-Madison researchers have developed a novel approach for enhancing pyroptosis, which could prove beneficial in treating cancer. The inventors combine intracellular delivery of gasdermin with a small...
Learn More
Learn More
Quanyin Hu, Zhaoting Li | P220290US02
Technology
Generating Allogenic Endothelial Cell-Seeded Vascular Grafts and Methods of Use Thereof
UW-Madison researchers have discovered that using allogenic arterial endothelial cells (not genetically modified to alter the immune response) perform better than hypoimmunogenic cells for producing s...
Learn More
Learn More
James Thomson, Jue Zhang, John Maufort | P220241US02